Enveric (ENVB) awards director Marcus Schabacker 18,518 restricted shares

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Schabacker Marcus reported acquisition or exercise transactions in this Form 4 filing.

Enveric Biosciences director Marcus Schabacker received a grant of 18,518 shares of restricted common stock under the company’s 2020 Long-Term Incentive Plan. The grant was awarded at no cash cost to him and will vest according to the plan and his award agreement. After this grant, he directly holds 26,418 shares of Enveric common stock.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Schabacker Marcus

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	18,518	$0.00	--

Holdings After Transaction: Common Stock — 26,418 shares (Direct, null)

Footnotes (1)

[object Object]

Key Figures

Restricted shares granted: 18,518 shares Grant price per share: $0.0000 per share Shares held after grant: 26,418 shares +1 more

4 metrics

Restricted shares granted 18,518 shares Restricted stock award on 2026-06-01

Grant price per share $0.0000 per share Stated price for restricted stock grant

Shares held after grant 26,418 shares Total direct common stock holdings after transaction

Transaction code A Grant, award, or other acquisition of common stock

Key Terms

restricted stock, 2020 Long-Term Incentive Plan, restricted stock award agreement, Grant, award, or other acquisition

4 terms

restricted stock financial

"Represents restricted stock granted to the reporting person pursuant to the Enveric Biosciences, Inc. 2020 Long-Term Incentive Plan"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

2020 Long-Term Incentive Plan financial

"pursuant to the Enveric Biosciences, Inc. 2020 Long-Term Incentive Plan, as amended"

restricted stock award agreement financial

"shall vest in accordance with the terms and conditions of the Plan and the reporting person's restricted stock award agreement"

A restricted stock award agreement is a legal contract that grants someone company shares that are subject to limits — for example, they may only become fully owned after working at the company for a set time, meeting performance goals, or otherwise satisfying conditions. For investors, these agreements matter because they shape insider incentives, future share dilution when restrictions lift, and company compensation costs; think of it like a gift locked in a box that opens only after certain conditions are met.

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

06/03/2026 - 04:27 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Schabacker Marcus

(Last)

(First)

(Middle)

245 FIRST STREET, RIVERVIEW II

18TH FLOOR

(Street)

CAMBRIDGE

MASSACHUSETTS

02142

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Enveric Biosciences, Inc. [ ENVB ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	06/01/2026		A		18,518⁽¹⁾	A	$0	26,418	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Represents restricted stock granted to the reporting person pursuant to the Enveric Biosciences, Inc. 2020 Long-Term Incentive Plan, as amended (the "Plan"). Such shares shall vest in accordance with the terms and conditions of the Plan and the reporting person's restricted stock award agreement.

	/s/ Marcus Schabacker	06/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Enveric Biosciences (ENVB) report for Marcus Schabacker?

Enveric Biosciences reported that director Marcus Schabacker received 18,518 shares of restricted common stock. The shares were granted under the 2020 Long-Term Incentive Plan and will vest based on the plan and his award agreement.

How many Enveric Biosciences (ENVB) shares does Marcus Schabacker hold after this Form 4?

After the reported grant, Marcus Schabacker directly holds 26,418 shares of Enveric Biosciences common stock. This total includes the newly awarded 18,518 restricted shares, which will vest over time according to plan terms.

Was cash paid for the Enveric Biosciences (ENVB) restricted stock granted to Marcus Schabacker?

No cash changed hands for this grant; the 18,518 restricted shares were awarded at a stated price of $0.0000 per share. This indicates a compensation-related equity award rather than an open-market stock purchase.

Under what plan was the Enveric Biosciences (ENVB) restricted stock granted to Marcus Schabacker?

The 18,518 restricted shares were granted under the Enveric Biosciences, Inc. 2020 Long-Term Incentive Plan, as amended. Vesting will follow the plan’s provisions and the specific restricted stock award agreement.

What does a restricted stock grant mean for an Enveric Biosciences (ENVB) director?

A restricted stock grant gives the director shares that vest over time or on conditions. For Marcus Schabacker, 18,518 restricted shares were granted and will vest per the 2020 Long-Term Incentive Plan and his award agreement.